Quantcast
Channel: Pharmaceuticals News
Browsing all 83 articles
Browse latest View live

Cancer Treatment for Colorectal Cancer Approved

The U.S. Food and Drug Administration (FDA) this week announced that it has approved a new drug for the treatment of colorectal cancer. According to the U.S. Centers for Disease Control and Prevention...

View Article



Cancer Treatment Kevetrin Begins Clinical Trials

Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center’s Dana-Farber Cancer Institute and Beth...

View Article

Cholesterol Drug Wins FDA Recommendation

Isis Pharmaceuticals recently announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) found the company’s drug, Kynamro (the trade name...

View Article

Multiple Sclerosis Drug ‘Reboots’ the Immune System

New trials show that a cancer drug can be an effective treatment for multiple sclerosis (MS) by ‘rebooting’ patients’ immune systems. The results of two phase III clinical trials were published today...

View Article

Arthritis Drug Approved by the U.S. FDA

The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to methotrexate. The...

View Article


Asthma Drug Rejected by U.K.’s NICE

The U.K.’s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an asthma medication marketed as Xolair by...

View Article

Diabetes Treatment Shown to Improve Memory For Alzheimer’s Patients

A new study shows that a drug used to treat insulin resistance in diabetics could improve cognitive performance in some people with Alzheimer’s disease. In the study, published this week in the Journal...

View Article

Grapefruit Warning For Medications Expanded

A review published this week in the Canadian Medical Association Journal (CMAJ) warns that while the number of prescription drugs that have adverse effects from interactions with grapefruit are...

View Article


Cholesterol Meds Most Effective With Exercise, Shows Study

A new study shows that cholesterol-lowering drugs have a more significant effect when combined with exercise. Though both the drugs and exercise lower the chances of premature death for people with...

View Article


Merck Drug Fails Major Clinical Trial

Merck, a major U.S. pharmaceutical company, announced this week that its drug “Tredaptive” has failed a clinical trial. The trial was meant to test the drug for its ability to improve patients’ heart...

View Article

Stroke Medication Approved by the U.S. FDA

A new anti-clotting drug has been approved by the U.S. Food and Drug Administration. Called apixaban and marketed by Bristol-Myers Squibb and Pfizer as Eliquis, the drug has been approved to reduce the...

View Article

Diabetes Drug Works Differently Than Was Previously Thought

For half a century one of the most popular and most-prescribed classes of diabetes drugs has been biguanides, which includes the drug metformin. Metformin helps to keep liver glucose output in check,...

View Article

Diabetes Drug Approved by U.S. FDA Committee

A U.S. Food and Drug Administration (FDA) committee this week approved the drug canagliflozin for the treatment of adults with type 2 diabetes. The Endrocrinologic and Metabolic Drugs Advisory...

View Article


Cholesterol Drug Tredaptive Pulled Worldwide

Less than one month ago, Merck, a major U.S. pharmaceutical company, announced that its cholesterol drug Tredaptive failed a major clinical trial. The drug is meant to improve heart health by...

View Article

Purdue, Maker of OxyContin, Keeps a List of Bad Docs

Earlier this year, the FDA made headlines when it prevented pharmaceutical giant Purdue Pharma from continuing to produce generic and crushable versions of the popular opioid OxyContin. The New York...

View Article


Merck Job Cuts On the Rise, Cuts Could Prove Beneficial

For months, the struggling New Jersey- based pharmaceutical conglomerate has been struggling, and the numbers they’ve been producing have only made their financial woes more evident. But, yesterday the...

View Article

Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims

The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has plead guilty over the misbranding of the drug Risperdal. Janssen and its...

View Article


Depression Drug Vyvanse Sent Back To Drawing Board

The pharmaceutical group Shire has decided to stop developing the drug Vyvanse for use to treat depression. The Amphetamine-based Vyvanse is a popular ADHD drug, having made over $1.2 billion dollars...

View Article

FDA Implements Pilot Program For Fast-Track Drug Importation

The U.S. Food and Drug Administration (FDA) today announced that it has begun its two-year Secure Supply Chain Pilot Program. The program is meant to streamline some drug importation for select...

View Article

New Painkiller Zohydro: What Parents And Patients Need To Know

Painkiller junkies who’ve diligently done research are anxiously awaiting the arrival of a pill called Zohydro. Meanwhile, a well-meaning coalition of health professionals is also anticipating – the...

View Article
Browsing all 83 articles
Browse latest View live




Latest Images